Skip to main content

Table 1 Phenotypic analysis of MDSCs from septic and control patients

From: Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis

 

% MDSC (of total leukocytes)

% M-MDSC (of total MDSCs)

% G-MDSC (of total MDSCs)

% CD14−CD15−MDSC (of total MDSCs)

Control (Q1, Q3)

3.00 (0.6, 5.0)

21.50 (8.7, 55.5)

5.60 (3.0, 12.2)

72.90

Sepsis day 4 (Q1, Q3)

4.50* (2.2, 8)

22.40 (12.5, 41.2)

7.90 (1.5, 19.3)

69.70

Sepsis day 14 (Q1, Q3)

4.90* (1.95, 8.55)

17.85# (10.2, 30.4)

10.55*,# (3.4, 30.60)

71.60

  1. % MDSC all myeloid-derived suppressor cell, M-MDSC monocytic myeloid-derived suppressor cell, G-MDSC granulocytic myeloid-derived suppressor cell
  2. *p < 0.05 vs control
  3. #p < 0.05 vs day 4
Back to article page

Critical Care

ISSN: 1364-8535